HER2
Clinical trials for HER2 explained in plain language.
Never miss a new study
Get alerted when new HER2 trials appear
Sign up with your email to follow new studies for HER2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy shows promise for hard-to-treat bile duct cancer
Disease control OngoingThis study tests a combination of chemotherapy (gemcitabine/cisplatin) plus two targeted drugs (trastuzumab and pembrolizumab) as a first treatment for people with HER2-positive bile duct or gallbladder cancer that cannot be removed by surgery. The goal is to see how well this tr…
Matched conditions: HER2
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 17, 2026 04:34 UTC
-
AI could replace biopsies for bladder cancer testing
Diagnosis ENROLLING_BY_INVITATIONThis study enrolls 4,000 people with bladder cancer to see if artificial intelligence can accurately predict HER2 protein levels using MRI scans and tissue samples. The goal is to create a fast, non-invasive tool that helps doctors decide on targeted therapy without needing extra…
Matched conditions: HER2
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Diagnosis
Last updated May 14, 2026 12:03 UTC